[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367586-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367586-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deletions-of-lpl-and-nkx31-in-prostate-cancer-progression-game-changers-or-by-standers-in-tumor-evolution","Deletions of LPL and NKX3.1 in Prostate Cancer Progression - Game Changers or By-Standers in Tumor Evolution","","The tumor suppressor gene NKX3.1 and the LPL gene lie in close proximity on chromosome 8, and their deletions have been reported in multiple studies. The study addresses whether LPL loss is a biologically meaningful event or merely a bystander effect alongside NKX3.1 loss in prostate carcinogenesis. Using 28 formalin-fixed paraffin-embedded prostate cancer samples with confirmed LPL deletion and 28 without, along with reanalysis of whole-genome sequencing data from 103 patients, the authors assessed protein expression, histology, and copy-number changes. Deletion of 8p21.3 correlated with higher Gleason grade groups, yet LPL protein expression showed no significant difference by cancer status or 8p21.3 deletion, supporting a passenger role for LPL deletion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deletions-of-lpl-and-nkx31-in-prostate-cancer-progression-game-changers-or-by-standers-in-tumor-evolution/367586/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deletions-of-lpl-and-nkx31-in-prostate-cancer-progression-game-changers-or-by-standers-in-tumor-evolution/367586.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is LPL deletion in prostate cancer potentially misinterpreted?","Question",{"text":63,"@type":64},"LPL loss occurs together with NKX3.1 deletion, a well-established event in prostate carcinogenesis. Co-deletion can make the biological significance of LPL loss difficult to disentangle from NKX3.1-driven effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What study design was used to test whether LPL deletion is a bystander event?",{"text":68,"@type":64},"The study compared prostate cancer samples with confirmed LPL deletion versus without, using immunohistochemical staining, and reanalyzed previously published whole-genome sequencing data from additional patients.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the results show about LPL protein expression and 8p21.3 deletion?",{"text":72,"@type":64},"NKX3.1 expression was reduced in cancer compared with benign tissue, but LPL protein expression did not differ significantly between cancerous and benign tissue and was not affected by 8p21.3 deletion status.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367586,1791384398,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Communication  \nDeletions of LPL and NKX3.1 in Prostate Cancer Progression: Game Changers or By-Standers in Tumor Evolution  \nTereza Vodiˇcková 1,2, Mária Wozniaková 1,2, Vladimír Židlík 1,2, *, Jana Žmolíková 3, Jana Dvoˇráˇcková 3, Adéla Kondé 4,5, Jana Schwarzerová 1,6,7, Michal Grepl 8 and Jan Bouchal 2, *  \nAcademic Editors: Piwen Wang and Alessandro Alaimo  \nReceived: 31 March 2025  \nRevised: 16 May 2025  \nAccepted: 16 May 2025  \nPublished: 24 May 2025  \nCitation: Vodiˇcková, T.; Wozniaková, M.; Židlík, V.; Žmolíková, J.;  \nDvoˇráˇcková, J.; Kondé, A.;  \nSchwarzerová, J.; Grepl, M.; Bouchal, J. Deletions of LPL and NKX3.1 in Prostate Cancer Progression: Game Changers or By-Standers in Tumor Evolution. Biomolecules 2025, 15, 758 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biom15060758  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Institute of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava and Medical Faculty Ostrava, 703 52 Ostrava, Czech Republic; [tereza.vodickova@fno.cz](tereza.vodickova@fno.cz) (T.V.);  \n[maria.wozniakova@fno.cz](maria.wozniakova@fno.cz) (M.W.); [jana.schwarzerova2@fno.cz](jana.schwarzerova2@fno.cz) (J.S.)  \n2 Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Palacky University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic  \n3 EUC Laboratories CGB, a.s., 703 00 Ostrava, Czech Republic; [jana.zmolikova@euclaboratore.cz](jana.zmolikova@euclaboratore.cz) (J.Ž .); [jana.dvorackova@euclaboratore.cz](jana.dvorackova@euclaboratore.cz) (J.D.)  \n4 Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB—Technical University of Ostrava, 708 00 Ostrava, Czech Republic; [adela.konde@vsb.cz](adela.konde@vsb.cz)  \n5 Department of Deputy Director for Science, Research and Education, University Hospital Ostrava,  \n703 00 Ostrava, Czech Republic  \n6 Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, 616 00 Brno, Czech Republic  \n7 Molecular Systems Biology (MOSYS), Department of Functional and Evolutionary Ecology, Faculty of Life Sciences, University of Vienna, 1030 Vienna, Austria  \n8 Department of Urology, University Hospital Ostrava, 703 52 Ostrava, Czech Republic; [michal.grepl@fno.cz](michal.grepl@fno.cz)  \n* [Correspondence: vladimir.zidlik@fno.cz](Correspondence: vladimir.zidlik@fno.cz) (V.Ž .); [jan.bouchal@upol.cz](jan.bouchal@upol.cz) (J.B.)  \nAbstract: The tumor suppressor gene NKX3.1 and the LPL gene are located in close proximity on chromosome 8, and their deletion has been reported in multiple studies. However, the significance of LPL loss may be misinterpreted due to its co-deletion with NKX3.1, a well-established event in prostate carcinogenesis. This study investigates whether LPL deletion represents a biologically relevant event or occurs merely as a bystander to NKX3.1 loss. We analyzed 28 formalin-fixed paraffin-embedded prostate cancer samples with confirmed LPL deletion and 28 without. Immunohistochemical staining was performed, and previously published whole-genome sequencing data from 103 prostate cancer patients were reanalyzed. Deletion of the 8p21.3 region was associated with higher Gleason grade groups. While NKX3.1 expression was significantly reduced in prostate cancer compared to benign prostatic hyperplasia, LPL protein expression showed no significant difference between cancerous and benign tissue, nor was it affected by the 8p21.3 deletion status. Copy number analysis confirmed the co-deletion of NKX3.1 and LPL in 54 patients. Notably, NKX3.1 los","cbCairFwydlbdupG","https://ap.wps.com/l/cbCairFwydlbdupG","pdf",4326835,12,"English","# Introduction\n## Tumor suppressor role of NKX3.1\n## Biological role of LPL and rationale for investigating co-deletion","[{\"question\":\"Why is LPL deletion in prostate cancer potentially misinterpreted?\",\"answer\":\"LPL loss occurs together with NKX3.1 deletion, a well-established event in prostate carcinogenesis. Co-deletion can make the biological significance of LPL loss difficult to disentangle from NKX3.1-driven effects.\"},{\"question\":\"What study design was used to test whether LPL deletion is a bystander event?\",\"answer\":\"The study compared prostate cancer samples with confirmed LPL deletion versus without, using immunohistochemical staining, and reanalyzed previously published whole-genome sequencing data from additional patients.\"},{\"question\":\"What did the results show about LPL protein expression and 8p21.3 deletion?\",\"answer\":\"NKX3.1 expression was reduced in cancer compared with benign tissue, but LPL protein expression did not differ significantly between cancerous and benign tissue and was not affected by 8p21.3 deletion status.\"}]","Deletions of LPL and NKX3.1 in Prostate Cancer Progression - Game Changers or By-Standers in Tumor Evolution | PDF",1790171510,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac05aa31f02b173f6e2e9662a6cbead2.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a97a3ff6d64ac9e129e02d122f714ecc.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cba51faab62959e913fafd8860bcac4c.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6efbfa65c132e0ca0eca923f26826bab.webp",980,1385]